Vascular Birthmark Latest Advances

Recognition and Management of Ulcerative Infantile Hemangioma: Risk Factors, Diagnosis, and Prognosis.

Journal: Pediatric annals

Published: September 03, 2026

Darbepoetin and Infantile Hemangioma in Premature Infants.

Journal: Journal of clinical medicine

Published: June 29, 2026

Literature Review of Long-Term Sequelae and Modern Management of Infantile Hemangioma.

Journal: Cureus

Published: June 22, 2026

Telocyte-derived pentraxin 3 enables vascular pruning as a key driver in infantile hemangioma regression.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: June 10, 2026

Refractory Ulcerated Infantile Hemangioma Successfully Treated With Bleomycin Sclerotherapy: A Case Report.

Journal: The American journal of case reports

Published: May 25, 2026

Differential effects and mechanistic associations of propranolol stereoisomers in infantile hemangioma endothelial cells.

Journal: 3 Biotech

Published: May 17, 2026

Integrative Bioinformatics Analysis and Machine Learning Reveal TSPAN7 Regulates the Involution of Infantile Hemangioma via NK Cells.

Journal: Clinical, cosmetic and investigational dermatology

Published: April 29, 2026

R-(+)-propranolol for infantile hemangioma: β-adrenoceptor-independent mechanisms and clinical translation prospects.

Journal: Frontiers in medicine

Published: April 23, 2026

Identification of shared hub genes CTNNB1, TJP1, PTK2, and TP53 associated with endothelial proliferation in infantile hemangioma and glioblastoma.

Journal: Mammalian genome : official journal of the International Mammalian Genome Society

Published: April 17, 2026

Determinants of proliferation and involution in infantile hemangioma: macrophage crosstalk, endothelial plasticity, and metabolic rewiring.

Journal: Frontiers in pediatrics

Published: April 05, 2026

Impact of propranolol formulation on treatment response and adverse events in infantile hemangioma: A single-center retrospective cohort study.

Journal: Medicine

Published: March 09, 2026

Efficacy and safety of oral propranolol combined with intralesional injection of lauromacrogol for infantile hemangioma: a systematic review and meta-analysis.

Journal: Translational pediatrics

Published: March 09, 2026

Vascular Birthmark Latest Advances

Find the Latest Research About Vascular Birthmark

Recognition and Management of Ulcerative Infantile Hemangioma: Risk Factors, Diagnosis, and Prognosis.

Recognition and Management of Ulcerative Infantile Hemangioma: Risk Factors, Diagnosis, and Prognosis.

Darbepoetin and Infantile Hemangioma in Premature Infants.

Darbepoetin and Infantile Hemangioma in Premature Infants.

Literature Review of Long-Term Sequelae and Modern Management of Infantile Hemangioma.

Literature Review of Long-Term Sequelae and Modern Management of Infantile Hemangioma.

Telocyte-derived pentraxin 3 enables vascular pruning as a key driver in infantile hemangioma regression.

Telocyte-derived pentraxin 3 enables vascular pruning as a key driver in infantile hemangioma regression.

Refractory Ulcerated Infantile Hemangioma Successfully Treated With Bleomycin Sclerotherapy: A Case Report.

Refractory Ulcerated Infantile Hemangioma Successfully Treated With Bleomycin Sclerotherapy: A Case Report.

Differential effects and mechanistic associations of propranolol stereoisomers in infantile hemangioma endothelial cells.

Differential effects and mechanistic associations of propranolol stereoisomers in infantile hemangioma endothelial cells.

Integrative Bioinformatics Analysis and Machine Learning Reveal TSPAN7 Regulates the Involution of Infantile Hemangioma via NK Cells.

Integrative Bioinformatics Analysis and Machine Learning Reveal TSPAN7 Regulates the Involution of Infantile Hemangioma via NK Cells.

R-(+)-propranolol for infantile hemangioma: β-adrenoceptor-independent mechanisms and clinical translation prospects.

R-(+)-propranolol for infantile hemangioma: β-adrenoceptor-independent mechanisms and clinical translation prospects.

Identification of shared hub genes CTNNB1, TJP1, PTK2, and TP53 associated with endothelial proliferation in infantile hemangioma and glioblastoma.

Identification of shared hub genes CTNNB1, TJP1, PTK2, and TP53 associated with endothelial proliferation in infantile hemangioma and glioblastoma.

Determinants of proliferation and involution in infantile hemangioma: macrophage crosstalk, endothelial plasticity, and metabolic rewiring.

Determinants of proliferation and involution in infantile hemangioma: macrophage crosstalk, endothelial plasticity, and metabolic rewiring.

Impact of propranolol formulation on treatment response and adverse events in infantile hemangioma: A single-center retrospective cohort study.

Impact of propranolol formulation on treatment response and adverse events in infantile hemangioma: A single-center retrospective cohort study.

Efficacy and safety of oral propranolol combined with intralesional injection of lauromacrogol for infantile hemangioma: a systematic review and meta-analysis.

Efficacy and safety of oral propranolol combined with intralesional injection of lauromacrogol for infantile hemangioma: a systematic review and meta-analysis.